ABT vs BSX · P/E 25, rev $44.33B vs P/E 20, rev $20.07B
Abbott Laboratories (ABT) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the ABT and BSX stock pages for the full models.
Not investment advice.